Clinical Insights & Research — 2026
The Journal.
Evidence-based peptide therapy insights, regulatory
updates, obesity and metabolism education, and practical
clinical guidance for modern providers.
Retatrutide: The Triple Agonist Changing How Clinicians Think About Obesity Medicine
by: Lauren SupraPublished on: 21/05/2026Retatrutide is still investigational. Long-term safety data is still needed, along with more research, and more clinical experience. However, medicine is entering a completely different era of metabolic treatment.
Why Most Clinicians Feel Unprepared for Peptide Therapy and What to Do About It
by: Lauren SupraPublished on: 08/05/2026Peptide therapy can feel hard to understand because clinicians are not just trying to learn a name or memorize what something is “used for.” They are trying to understand what that peptide is doing in the body, what it is signaling, what system
Why So Many Clinicians Are Confused About Peptide Regulations Right Now
by: Lauren SupraPublished on: 28/04/2026Healthcare professionals need better education so they can evaluate this field responsibly, educate patients honestly, and think critically through what may or may not make sense in clinical practice.
Join the mailing list and receive 15% off your first course enrollment
Get course updates, peptide education insights, and a special first-time enrollment offer
Dedicated to the advancement of clinical excellence through evidence-based peptide therapy education.
Quick Links
Our Commitment
Advancing clinical excellence through education you can trust and apply.
© 2026 Advera Care - All Rights Reserved.
Designed by Joamar Derije [Autobookr.io]
